Drugmakers Face Deadline to Cut US Prescription Costs or Face Action

Drug Pricing Deadline and Global Disparities

• 🇺🇸 Americans pay the highest prices in the world for prescription drugs, a situation President Trump aims to change.
• 🎯 A deadline has been set for drugmakers to lower prescription costs in the United States, with threats of further action against non-compliant companies.
• 🌍 Both drugmakers and Trump officials acknowledge that European nations pay significantly less for medicines than the US.

Drugmaker Responses and Industry Arguments

• ⚖️ Some companies have attempted to appease the White House by raising prices abroad, but have stopped short of lowering them domestically.
• 📈 Examples include Eli Lilly increasing the price of Munjaro in the UK and Bristol Myers Squib hiking the cost of its schizophrenia treatment Cobeny in the UK to match US prices.
• 💡 Drug manufacturers argue that the American market fuels innovation and that foreign countries should bear more of the cost, not US companies.
• 🗣️ Pharma's statement suggests that importing foreign price controls would undermine American leadership and hurt patients and workers.

Potential Government Actions

• 📺 If companies do not comply with the new model, President Trump has indicated that new penalties are being considered.
• ⚠️ One floated penalty includes pulling drug advertisements off television.
• 🔍 The HHS has sent a new drug pricing list, the Global Benchmark to Efficient Drug Pricing (GLOBE), to the White House for review.